BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor (World)
Aurinia (ISA.TO) Announces Results Of Annual General Meeting 5/28/2015
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself 5/27/2015
Tianyin Pharmaceutical Co, Inc. Adjourned Its 2014 Annual Shareholder Meeting And Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 5/27/2015
Israeli Biotech Company Vaxil Bio To List On Toronto Stock Exchange Venture Through Reverse Takeover With Emerge Resources 5/27/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 5/26/2015
Resolutions Adopted By The Extraordinary General Meeting In Karo Bio AB Held On May 25, 2015 5/26/2015
Portage Biotech Announces Proposed Private Placement 5/20/2015
Valeant (VRX) Announces 2015 Annual Meeting Results 5/20/2015
GW Pharma (GWPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional American Depositary Shares 5/18/2015
BioInvent (BOVNF): BioInvent’s Rights Issue Oversubscribed 5/18/2015
Valeant (VRX) To Webcast 2015 Annual Meeting Of Shareholders 5/13/2015
Report From The 2015 Annual General Meeting In Aerocrine 5/13/2015
Onxeo: Publication Of A Letter To Shareholders – May 2015 5/13/2015
Skyepharma PLC (SKYEF) AGM Trading Update 5/12/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 Held By Cordlife And Magnum And Its Ordinary Shares Held By CordLife Ltd. 5/8/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
Affimed Therapeutics AG (AFMD) Announces Pricing Of Public Offering Of Common Stock 5/7/2015
GENFIT (ALGFT) Announces Its Turnover And Cash Situation As Of March 31, 2015 5/7/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Galapagos (GLPG.BR) Announces Launch Of Proposed Global Offering 5/6/2015
Galapagos (GLPG.BR) Listed 10 Years On Euronext Amsterdam And Brussels 5/6/2015
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
China Cord Blood Corporation Receives Notice Of A Transaction Regarding Its 7% Senior Convertible Notes Due 2017 Held By KKR 5/4/2015
Tikcro Technologies Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Macrocure (MCUR) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
WuXi PharmaTech Co., Ltd. Announces Receipt Of Proposal 5/1/2015
WuXi PharmaTech Co., Ltd. Receives $3.2 Billion Privatization Offer 4/30/2015
Sinovac Biotech Ltd. (SVA) Files 2014 Annual Report On Form 20-F 4/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015
Novogen Limited (NVGN) Completes The Private Placement Of Equity 4/29/2015
NeuroDerm Ltd. (NDRM) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 4/29/2015
ProQR Therapeutics B.V. (PRQR) Announces Annual Shareholder Meeting 4/29/2015
Sobi's Board Of Directors Postpones Annual General Meeting Of Shareholders 4/29/2015
Basilea Pharmaceutica (BSLN.SW) Shareholders Approve All Resolutions Proposed By The Board Of Directors At The Ordinary General Meeting Of Shareholders 4/29/2015
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs 4/28/2015
China Cord Blood Corporation Receives $512 Million Take-Private Offer 4/28/2015
Novogen Limited (NVGN) Regains Full Compliance With NASDAQ Listing Rule 4/28/2015
Syngenta AG (SYT) Annual General Meeting 4/28/2015
ERYtech Pharma Receives The EnterNext Tech 40 Label 4/28/2015
Precise Biometrics AB: Resolutions At Precise Biometrics´ Annual General Meeting 2015 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015
Nordic Nanovector – Share Capital Increase Registered 4/24/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015 4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 4/23/2015
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB 4/23/2015
Horizon Pharma (HZNP) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
Tiziana Life Sciences Plc Release: Issue Of Convertible Loan Notes And Warrants 4/22/2015
Annual General Meeting In BioInvent (BOVNF) 4/22/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares 4/20/2015
Admedus Completes Fully Subscribed $16.1 Million Rights Issue 4/17/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/17/2015
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 4/15/2015
uniQure (QURE) Announces Pricing Of Follow-On Public Offering 4/10/2015
Cellular Biomedicine Group (CBMG) Upgraded To NASDAQ Global Market 4/10/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Replicel Life Sciences Receives TSX Venture Exchange Approval To Extend Warrant Expiry Dates 4/8/2015
Prothena (PRTA) Announces Pricing Of Public Offering Of 3,300,000 Ordinary Shares 4/8/2015
Lonza Group Ltd. (LZAGY.PK) Announces Results Of Annual General Meeting Annual General Meeting Accepts All Motions Proposed By Board Of Directors 4/8/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst 4/8/2015
Prothena (PRTA) Announces Proposed Offering of Ordinary Shares 4/7/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Mallinckrodt (MNK) Launches Notes Offering 4/6/2015
WuXi PharmaTech Co., Ltd. Lists Shares Of Small-Molecule Manufacturing Subsidiary STA On New Third Board In China 4/3/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi 4/2/2015
Trinity Biotech plc Announces Proposed Offering Of $100 Million Of Exchangeable Senior Notes Due 2045 4/2/2015
Salix (SLXP) Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes And Merger Event Relating To Its 1.5% Convertible Senior Notes Due 2019 4/2/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Files Registration Statement For Proposed Follow-On Offering 4/2/2015
BTG plc (BTG.L): Close Period Update 4/2/2015
Valeant (VRX) Completes Tender Offer For Salix (SLXP) 4/1/2015
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities 4/1/2015
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015
NeuroVive Pharmaceutical AB (publ) - Amendment Number Of Shares And Votes 3/31/2015
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB) 3/30/2015
Covalon Technologies Ltd. Announces Issuance Of Stock Options 3/30/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
BioPharm Executive: Why Your Last Investment Blew Up 3/26/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/20/2015
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015
Admedus Announces Placement And Rights Issue 3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst 3/17/2015
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015
Polar Capital Funds Plc And Fmr Llc Provide Notification Of Shareholding In Ablynx (ABLYF) 3/16/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 3/16/2015
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 3/16/2015
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015
Ablynx (ABLYF) Announces Warrant Exercise 3/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS 3/16/2015
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015
Replicel Life Sciences In Japan For Key Industry Meetings 3/12/2015
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015
Actavis (ACT) Announces Closing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/12/2015
Lonza Group Ltd. (LZAGY.PK) Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting 3/11/2015
SYGNIS To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 3/10/2015
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index 3/6/2015
PhytoTech Medical Limited (ASX:PYL) Investor Presentation 3/6/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib 3/5/2015
Actavis (ACT) Announces Pricing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/4/2015
Neovacs SA Scientific Advisory Board Endorses Company's Updated IFNa-Kinoid Development Plan 3/4/2015
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 3/3/2015
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014 3/3/2015
Aviva Plc And Aviva Investors Global Services Limited Provide Notification Of A 5.02% Shareholding In Ablynx (ABLYF) 3/3/2015
Alnylam (ALNY)’s “Incredibly Deep” Pipeline Continues to Impress As Commercial Stage Looms, Says Analyst 3/2/2015
InMed To Present Investor Webcast March 5 3/2/2015
Karolinska Development AB Confirms Full Payment In The Rights Issue Of Convertibles 3/2/2015
Actavis (ACT) Announces Proposed Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/2/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Teva Pharmaceutical Industries (TEVA) Announces Early Results Of Debt Tender Offer, Pricing, Election Of Early Settlement And Increase In Maximum Amount And Priority 2 Notes Tender Cap 2/27/2015
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 2/27/2015
Cardio3 BioSciences To Raise Capital Via A Private Placement Of New Shares 2/26/2015
Actavis (ACT) Announces Pricing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 2/25/2015
Alkermes plc (ALKS) Announces Webcast Of Analyst And Investor Event On March 2, 2015 2/24/2015
GENFIT Corp. (ALGFT): Minutes Of The Combined General Shareholders' Meeting Of February 24, 2015 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
RedHill Biopharma Ltd. (RDHL) Announces Full Exercise Of Underwriters' Over-Allotment Option 2/18/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 2/13/2015
VolitionRX Announces Closing Of Public Offering Of Common Stock 2/12/2015
Transition Therapeutics Inc. (TTH.TO) Announces Pricing Of Public Offering Of US$20 Million Of Common Shares 2/12/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 2/10/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 2/10/2015
Suven Life Sciences Ltd Revenue Growth At 9% While PAT Is Down By 11.55% For The 3rd Quarter Ended Dec 2014 2/10/2015
BIOCEO15: Kite Pharma (KITE) Debuts Near-Term Plans, Says It’s Tackling "Toxicity Issues" 2/10/2015
BIOCEO15: New Report On Biotech Venture Capital Over Last 10 Years Finds Heavy Focus on R&D 2/10/2015
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest" 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
BNP Paribas Notify Of 5.08% Shareholding In Galapagos NV (GLPG.BR) 2/9/2015
VolitionRX Prices Public Offering of Common Stock 2/6/2015
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival 2/5/2015
Macrocure (MCUR) Announces Special General Meeting Of Shareholders For Approval Of Amendments To Compensation Package Of CEO And 2013 Share Incentive Plan 2/5/2015
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At Two Upcoming Conferences 2/4/2015
Forget Smartphones—Genomic Data is the Next Big Deal, Says Edico Genome CEO 2/4/2015
Summit Corporation Files Registration Statement For Proposed U.S. Public Offering And Applies For NASDAQ Listing 2/2/2015
Admedus Release: Announcement To The Australian Stock Exchange 2/2/2015
Oxford Immunotec Limited (OXFD) Announces Proposed Underwritten Offering Of Ordinary Shares 1/29/2015
Future Of Healthcare Investor Forum Highlights Investment Opportunity In UK Life Sciences 1/29/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/28/2015
Ascendis Pharma A/S Announces Pricing Of Initial Public Offering 1/28/2015
ESSA Pharma Inc. Lists On The TSX Venture Exchange 1/28/2015
AnaMar Announces Strategic Realignment And 2015 Corporate Priorities 1/28/2015
Oxford Immunotec Global PLC Announces Proposed Underwritten Offering Of Ordinary Shares 1/28/2015
Cortendo AB: Notification Of Trade 1/27/2015
Medivir AB (MVRBF)’s CEO Increases His Shareholding In The Company 1/27/2015
Amgen (AMGN) Beats Street’s Earnings Estimates, Ready for Biosimilars, Says Citi 1/27/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/27/2015
Ultimovacs Carries Out NOK 45 Million Share Issue With Canica AS And Sundt AS As The Main Investors 1/22/2015
Ablynx (ABLYF) Announces Warrant Exercise 1/21/2015
Endo International (ENDP) Announces Pricing of Private Offering Of Senior Notes 1/21/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 1/20/2015
NeuroDerm Ltd. (NDRM) Announces Extraordinary General Meeting Of Shareholders For Ratification Of Election Of External Directors And Adoption Of Compensation Policy 1/20/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 1/20/2015
Horizon Discovery Group plc Trading Update 1/19/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 1/15/2015
Alcobra (ADHD) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Over-Allotment Option 1/14/2015
Debiopharm Diagnostics Leads Investment Round In GenePOC With Emerillon Capital 1/14/2015
ProSensa Holding N.V. (RNA) Announces Shareholder Approval Of Certain Matters Relating To The BioMarin (BMRN) Tender Offer 1/13/2015
Cardio3 BioSciences To Host Investor & Analyst Day In New York On Friday, January 30, 2015 1/13/2015
Allergy Therapeutics plc Release: Trading Update 1/12/2015
Skyepharma PLC (SKYEF) Release: Pre-Close Update 1/12/2015
ERYtech Pharma Announces ADR Level 1 Listing In The U.S. 1/12/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 1/12/2015
MGB Biopharma Limited Continues To Progress Its Truly Novel Anti-Infectives Platform To Tackle Antibiotic Resistance In 2014 1/12/2015
Fountain Healthcare's New €85 Million Fund to Create New Jobs in Biotech, Medtech 1/9/2015
Alcobra (ADHD) Announces Commencement Of Public Offering Of Ordinary Shares 1/9/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 1/9/2015
China Biologic Products Adopts Stockholder Rights Plan 1/9/2015
Seventure Invests EUR 1 M (USD 1.25 M) In First Investment Round For MaaT Pharma™ 1/9/2015
EXCLUSIVE: Developing World Needs Different Pricing Model, Naia Limited CEO Tells BioSpace (DHX) 1/9/2015
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015
Fundamentals Still Strong for Large Cap Biotech, But Headwinds Remain 1/7/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 1/6/2015
The FDA’s Breakthrough Therapy Program By the Numbers 1/5/2015
Protalix Biotherapeutics, Inc. (PLX) Announces New Strategy For Accelerated Growth 1/5/2015
RedHill Biopharma Ltd. (RDHL) Business Outlook And Anticipated Key Milestones For 2015 1/5/2015
Enzymotec Announces An Extraordinary General Meeting Of Shareholders 1/5/2015
Biotech Investors Surge Happily Into New Year, “Frothy” or Not, Says Cowen 1/5/2015
Tianyin Pharmaceutical Co, Inc. Updates on Alliance Discussion 1/2/2015
AmpliPhi Biosciences Corporation (APHB) To Host Shareholder Update Conference Call 12/31/2014